APO Research

APO RESEARCH · REPORT

EUV Pellicle

Selected research

Market Outlook & Growth Opportunities

Global EUV Pellicle Market Outlook and Growth Opportunities 2026

Market perspective

The global EUV Pellicle market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for EUV Pellicle is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for EUV Pellicle is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for EUV Pellicle is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the EUV Pellicle market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the EUV Pellicle market include Mitsui Chemicals, S&S Tech, Canatu, TSMC and FST, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global EUV Pellicle market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of EUV Pellicle and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents EUV Pellicle sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the EUV Pellicle market size, projected growth trends, production technologies, key applications, and end-use industries.

EUV Pellicle Segment by Company

Mitsui Chemicals

S&S Tech

Canatu

TSMC

FST

EUV Pellicle Segment by Type

≥90% transmittance

<90% transmittance

EUV Pellicle Segment by Application

IDM

Foundry

EUV Pellicle Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global EUV Pellicle status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions EUV Pellicle market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify EUV Pellicle significant trends, drivers, influence factors in global and regions.

6. To analyze EUV Pellicle competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EUV Pellicle market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of EUV Pellicle and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EUV Pellicle.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the EUV Pellicle market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global EUV Pellicle industry.

Chapter 3: Detailed analysis of EUV Pellicle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of EUV Pellicle in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of EUV Pellicle in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. EUV Pellicle Industry Trends Table 2. EUV Pellicle Industry Drivers Table 3. EUV Pellicle Industry Opportunities and Challenges Table 4. EUV Pellicle Industry Restraints Table 5. Global EUV Pellicle Revenue by Company (US$ Million) & (2021-2026) Table 6. Global EUV Pellicle Revenue Share by Company (2021-2026) Table 7. Global EUV Pellicle Sales Volume by Company (k m²) & (2021-2026) Table 8. Global EUV Pellicle Sales Volume Share by Company (2021-2026) Table 9. Global EUV Pellicle Average Price (USD/m²) of Company (2021-2026) Table 10. Global EUV Pellicle Company Ranking, (2024-2026) & (USD Million) Table 11. Global EUV Pellicle Key Company Manufacturing Base & Headquarters Table 12. Global EUV Pellicle Company, Product Type & Application Table 13. Global EUV Pellicle Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global EUV Pellicle by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of ≥90% transmittance Table 18. Significant Companies of <90% transmittance Table 19. Global EUV Pellicle Sales Volume by Type 2021 VS 2025 VS 2032 (k m²) Table 20. Global EUV Pellicle Sales Volume by Type (2021-2026) & (k m²) Table 21. Global EUV Pellicle Sales Volume by Type (2027-2032) & (k m²) Table 22. Global EUV Pellicle Sales Volume Share by Type (2021-2026) Table 23. Global EUV Pellicle Sales Volume Share by Type (2027-2032) Table 24. Global EUV Pellicle Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global EUV Pellicle Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global EUV Pellicle Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global EUV Pellicle Sales Value Share by Type (2021-2026) Table 28. Global EUV Pellicle Sales Value Share by Type (2027-2032) Table 29. Significant Companies of IDM Table 30. Significant Companies of Foundry Table 31. Global EUV Pellicle Sales Volume by Application 2021 VS 2025 VS 2032 (k m²) Table 32. Global EUV Pellicle Sales Volume by Application (2021-2026) & (k m²) Table 33. Global EUV Pellicle Sales Volume by Application (2027-2032) & (k m²) Table 34. Global EUV Pellicle Sales Volume Share by Application (2021-2026) Table 35. Global EUV Pellicle Sales Volume Share by Application (2027-2032) Table 36. Global EUV Pellicle Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global EUV Pellicle Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global EUV Pellicle Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global EUV Pellicle Sales Value Share by Application (2021-2026) Table 40. Global EUV Pellicle Sales Value Share by Application (2027-2032) Table 41. Global EUV Pellicle Sales by Region: 2021 VS 2025 VS 2032 (k m²) Table 42. Global EUV Pellicle Sales by Region (2021-2026) & (k m²) Table 43. Global EUV Pellicle Sales Market Share by Region (2021-2026) Table 44. Global EUV Pellicle Sales by Region (2027-2032) & (k m²) Table 45. Global EUV Pellicle Sales Market Share by Region (2027-2032) Table 46. Global EUV Pellicle Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global EUV Pellicle Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global EUV Pellicle Sales Value Share by Region (2021-2026) Table 49. Global EUV Pellicle Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global EUV Pellicle Sales Value Share by Region (2027-2032) Table 51. Global EUV Pellicle Market Average Price (USD/m²) by Region (2021-2026) Table 52. Global EUV Pellicle Market Average Price (USD/m²) by Region (2027-2032) Table 53. Global EUV Pellicle Sales by Country: 2021 VS 2025 VS 2032 (k m²) Table 54. Global EUV Pellicle Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global EUV Pellicle Sales by Country (2021-2026) & (k m²) Table 56. Global EUV Pellicle Sales Market Share by Country (2021-2026) Table 57. Global EUV Pellicle Sales by Country (2027-2032) & (k m²) Table 58. Global EUV Pellicle Sales Market Share by Country (2027-2032) Table 59. Global EUV Pellicle Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global EUV Pellicle Sales Value Market Share by Country (2021-2026) Table 61. Global EUV Pellicle Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global EUV Pellicle Sales Value Market Share by Country (2027-2032) Table 63. Mitsui Chemicals Company Information Table 64. Mitsui Chemicals Business Overview Table 65. Mitsui Chemicals EUV Pellicle Sales (k m²), Value (US$ Million), Price (USD/m²) and Gross Margin (2021-2026) Table 66. Mitsui Chemicals EUV Pellicle Product Portfolio Table 67. Mitsui Chemicals Recent Development Table 68. S&S Tech Company Information Table 69. S&S Tech Business Overview Table 70. S&S Tech EUV Pellicle Sales (k m²), Value (US$ Million), Price (USD/m²) and Gross Margin (2021-2026) Table 71. S&S Tech EUV Pellicle Product Portfolio Table 72. S&S Tech Recent Development Table 73. Canatu Company Information Table 74. Canatu Business Overview Table 75. Canatu EUV Pellicle Sales (k m²), Value (US$ Million), Price (USD/m²) and Gross Margin (2021-2026) Table 76. Canatu EUV Pellicle Product Portfolio Table 77. Canatu Recent Development Table 78. TSMC Company Information Table 79. TSMC Business Overview Table 80. TSMC EUV Pellicle Sales (k m²), Value (US$ Million), Price (USD/m²) and Gross Margin (2021-2026) Table 81. TSMC EUV Pellicle Product Portfolio Table 82. TSMC Recent Development Table 83. FST Company Information Table 84. FST Business Overview Table 85. FST EUV Pellicle Sales (k m²), Value (US$ Million), Price (USD/m²) and Gross Margin (2021-2026) Table 86. FST EUV Pellicle Product Portfolio Table 87. FST Recent Development Table 88. Key Raw Materials Table 89. Raw Materials Key Suppliers Table 90. EUV Pellicle Distributors List Table 91. EUV Pellicle Customers List Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. EUV Pellicle Product Image Figure 2. Global EUV Pellicle Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global EUV Pellicle Sales Value (2021-2032) & (US$ Million) Figure 4. Global EUV Pellicle Sales (2021-2032) & (k m²) Figure 5. Global EUV Pellicle Sales Average Price (USD/m²) & (2021-2032) Figure 6. Global EUV Pellicle Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. ≥90% transmittance Image Figure 10. <90% transmittance Image Figure 11. Global EUV Pellicle Sales Volume by Type (2021 VS 2025 VS 2032) & (k m²) Figure 12. Global EUV Pellicle Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global EUV Pellicle Sales Volume Share by Type (2021-2032) Figure 14. Global EUV Pellicle Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global EUV Pellicle Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global EUV Pellicle Sales Value Share by Type (2021-2032) Figure 17. IDM Image Figure 18. Foundry Image Figure 19. Global EUV Pellicle Sales Volume by Application (2021 VS 2025 VS 2032) & (k m²) Figure 20. Global EUV Pellicle Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global EUV Pellicle Sales Volume Share by Application (2021-2032) Figure 22. Global EUV Pellicle Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global EUV Pellicle Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global EUV Pellicle Sales Value Share by Application (2021-2032) Figure 25. Global EUV Pellicle Sales by Region: 2021 VS 2025 VS 2032 (k m²) Figure 26. Global EUV Pellicle Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global EUV Pellicle Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global EUV Pellicle Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America EUV Pellicle Sales Value (2021-2032) & (US$ Million) Figure 30. North America EUV Pellicle Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe EUV Pellicle Sales Value (2021-2032) & (US$ Million) Figure 32. Europe EUV Pellicle Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific EUV Pellicle Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific EUV Pellicle Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America EUV Pellicle Sales Value (2021-2032) & (US$ Million) Figure 36. South America EUV Pellicle Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa EUV Pellicle Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa EUV Pellicle Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt EUV Pellicle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt EUV Pellicle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt EUV Pellicle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. EUV Pellicle Value Chain Figure 124. Manufacturing Cost Structure Figure 125. EUV Pellicle Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • ≥90% transmittance
  • <90% transmittance
Applications
  • IDM
  • Foundry
Companies covered
  • Mitsui Chemicals
  • S&S Tech
  • Canatu
  • TSMC
  • FST

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global EUV Pellicle Sales Value (2021-2032)
  4. 1.2.2 Global EUV Pellicle Sales Volume (2021-2032)
  5. 1.2.3 Global EUV Pellicle Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 EUV Pellicle Market Dynamics
  1. 2.1 EUV Pellicle Industry Trends
  2. 2.2 EUV Pellicle Industry Drivers
  3. 2.3 EUV Pellicle Industry Opportunities and Challenges
  4. 2.4 EUV Pellicle Industry Restraints
3 EUV Pellicle Market by Company
  1. 3.1 Global EUV Pellicle Company Revenue Ranking in 2025
  2. 3.2 Global EUV Pellicle Revenue by Company (2021-2026)
  3. 3.3 Global EUV Pellicle Sales Volume by Company (2021-2026)
  4. 3.4 Global EUV Pellicle Average Price by Company (2021-2026)
  5. 3.5 Global EUV Pellicle Company Ranking (2024-2026)
  6. 3.6 Global EUV Pellicle Company Manufacturing Base and Headquarters
  7. 3.7 Global EUV Pellicle Company Product Type and Application
  8. 3.8 Global EUV Pellicle Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global EUV Pellicle Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 EUV Pellicle Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 EUV Pellicle Market by Type
  1. 4.1 EUV Pellicle Type Introduction
  2. 4.1.1 ≥90% transmittance
  3. 4.1.2 <90% transmittance
  4. 4.2 Global EUV Pellicle Sales Volume by Type
  5. 4.2.1 Global EUV Pellicle Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global EUV Pellicle Sales Volume by Type (2021-2032)
  7. 4.2.3 Global EUV Pellicle Sales Volume Share by Type (2021-2032)
  8. 4.3 Global EUV Pellicle Sales Value by Type
  9. 4.3.1 Global EUV Pellicle Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global EUV Pellicle Sales Value by Type (2021-2032)
  11. 4.3.3 Global EUV Pellicle Sales Value Share by Type (2021-2032)
5 EUV Pellicle Market by Application
  1. 5.1 EUV Pellicle Application Introduction
  2. 5.1.1 IDM
  3. 5.1.2 Foundry
  4. 5.2 Global EUV Pellicle Sales Volume by Application
  5. 5.2.1 Global EUV Pellicle Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global EUV Pellicle Sales Volume by Application (2021-2032)
  7. 5.2.3 Global EUV Pellicle Sales Volume Share by Application (2021-2032)
  8. 5.3 Global EUV Pellicle Sales Value by Application
  9. 5.3.1 Global EUV Pellicle Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global EUV Pellicle Sales Value by Application (2021-2032)
  11. 5.3.3 Global EUV Pellicle Sales Value Share by Application (2021-2032)
6 EUV Pellicle Regional Sales and Value Analysis
  1. 6.1 Global EUV Pellicle Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global EUV Pellicle Sales by Region (2021-2032)
  3. 6.2.1 Global EUV Pellicle Sales by Region: 2021-2026
  4. 6.2.2 Global EUV Pellicle Sales by Region (2027-2032)
  5. 6.3 Global EUV Pellicle Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global EUV Pellicle Sales Value by Region (2021-2032)
  7. 6.4.1 Global EUV Pellicle Sales Value by Region: 2021-2026
  8. 6.4.2 Global EUV Pellicle Sales Value by Region (2027-2032)
  9. 6.5 Global EUV Pellicle Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America EUV Pellicle Sales Value (2021-2032)
  12. 6.6.2 North America EUV Pellicle Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe EUV Pellicle Sales Value (2021-2032)
  15. 6.7.2 Europe EUV Pellicle Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific EUV Pellicle Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific EUV Pellicle Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America EUV Pellicle Sales Value (2021-2032)
  21. 6.9.2 South America EUV Pellicle Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa EUV Pellicle Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa EUV Pellicle Sales Value Share by Country, 2025 VS 2032
7 EUV Pellicle Country-level Sales and Value Analysis
  1. 7.1 Global EUV Pellicle Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global EUV Pellicle Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global EUV Pellicle Sales by Country (2021-2032)
  4. 7.3.1 Global EUV Pellicle Sales by Country (2021-2026)
  5. 7.3.2 Global EUV Pellicle Sales by Country (2027-2032)
  6. 7.4 Global EUV Pellicle Sales Value by Country (2021-2032)
  7. 7.4.1 Global EUV Pellicle Sales Value by Country (2021-2026)
  8. 7.4.2 Global EUV Pellicle Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA EUV Pellicle Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada EUV Pellicle Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico EUV Pellicle Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany EUV Pellicle Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France EUV Pellicle Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. EUV Pellicle Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy EUV Pellicle Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain EUV Pellicle Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia EUV Pellicle Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands EUV Pellicle Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries EUV Pellicle Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China EUV Pellicle Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan EUV Pellicle Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea EUV Pellicle Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India EUV Pellicle Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia EUV Pellicle Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia EUV Pellicle Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil EUV Pellicle Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina EUV Pellicle Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile EUV Pellicle Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia EUV Pellicle Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru EUV Pellicle Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia EUV Pellicle Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel EUV Pellicle Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE EUV Pellicle Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey EUV Pellicle Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran EUV Pellicle Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran EUV Pellicle Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt EUV Pellicle Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt EUV Pellicle Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt EUV Pellicle Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Mitsui Chemicals
  2. 8.1.1 Mitsui Chemicals Company Information
  3. 8.1.2 Mitsui Chemicals Business Overview
  4. 8.1.3 Mitsui Chemicals EUV Pellicle Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Mitsui Chemicals EUV Pellicle Product Portfolio
  6. 8.1.5 Mitsui Chemicals Recent Developments
  7. 8.2 S&S Tech
  8. 8.2.1 S&S Tech Company Information
  9. 8.2.2 S&S Tech Business Overview
  10. 8.2.3 S&S Tech EUV Pellicle Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 S&S Tech EUV Pellicle Product Portfolio
  12. 8.2.5 S&S Tech Recent Developments
  13. 8.3 Canatu
  14. 8.3.1 Canatu Company Information
  15. 8.3.2 Canatu Business Overview
  16. 8.3.3 Canatu EUV Pellicle Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Canatu EUV Pellicle Product Portfolio
  18. 8.3.5 Canatu Recent Developments
  19. 8.4 TSMC
  20. 8.4.1 TSMC Company Information
  21. 8.4.2 TSMC Business Overview
  22. 8.4.3 TSMC EUV Pellicle Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 TSMC EUV Pellicle Product Portfolio
  24. 8.4.5 TSMC Recent Developments
  25. 8.5 FST
  26. 8.5.1 FST Company Information
  27. 8.5.2 FST Business Overview
  28. 8.5.3 FST EUV Pellicle Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 FST EUV Pellicle Product Portfolio
  30. 8.5.5 FST Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 EUV Pellicle Value Chain Analysis
  2. 9.1.1 EUV Pellicle Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 EUV Pellicle Sales Mode & Process
  6. 9.2 EUV Pellicle Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 EUV Pellicle Distributors
  9. 9.2.3 EUV Pellicle Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research